Targeted KRASG12V Degradation In Vivo Elicits Lung Adenocarcinoma Regression with Subsequent Relapse from Dysregulated Proteolysis.

Martín A, García-Pérez IM, San José S, Rojo P, Riego-Mejías C, Teodosio C, Barbosa BMG, Sánchez-Zarzalejo C, Folch-I-Casanovas I, Odena Caballol A, Jarió S, Hijazo-Pechero S, Rodríguez-López SM, Entrialgo-Cadierno R, Nokin MJ, Muñoz-Félix JM, Loa D, Guruceaga E, Stephan-Otto Attolini C, Ambrogio C, Villanueva A, Vicent S, Riera A, Santamaría D, Mayor-Ruiz C

Open source

DOI: 10.1158/0008-5472.can-25-5172
Published: 2026 Aug 14
Container: Cancer research
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1158/0008-5472.can-25-5172,
  title = {Targeted KRASG12V Degradation In Vivo Elicits Lung Adenocarcinoma Regression with Subsequent Relapse from Dysregulated Proteolysis.},
  author = {Martín A and García-Pérez IM and San José S and Rojo P and Riego-Mejías C and Teodosio C and Barbosa BMG and Sánchez-Zarzalejo C and Folch-I-Casanovas I and Odena Caballol A and Jarió S and Hijazo-Pechero S and Rodríguez-López SM and Entrialgo-Cadierno R and Nokin MJ and Muñoz-Félix JM and Loa D and Guruceaga E and Stephan-Otto Attolini C and Ambrogio C and Villanueva A and Vicent S and Riera A and Santamaría D and Mayor-Ruiz C},
  year = {2026},
  journal = {Cancer research},
  doi = {10.1158/0008-5472.can-25-5172},
  url = {https://doi.org/10.1158/0008-5472.can-25-5172}
}

RIS

TY  - JOUR
TI  - Targeted KRASG12V Degradation In Vivo Elicits Lung Adenocarcinoma Regression with Subsequent Relapse from Dysregulated Proteolysis.
AU  - Martín A
AU  - García-Pérez IM
AU  - San José S
AU  - Rojo P
AU  - Riego-Mejías C
AU  - Teodosio C
AU  - Barbosa BMG
AU  - Sánchez-Zarzalejo C
AU  - Folch-I-Casanovas I
AU  - Odena Caballol A
AU  - Jarió S
AU  - Hijazo-Pechero S
AU  - Rodríguez-López SM
AU  - Entrialgo-Cadierno R
AU  - Nokin MJ
AU  - Muñoz-Félix JM
AU  - Loa D
AU  - Guruceaga E
AU  - Stephan-Otto Attolini C
AU  - Ambrogio C
AU  - Villanueva A
AU  - Vicent S
AU  - Riera A
AU  - Santamaría D
AU  - Mayor-Ruiz C
PY  - 2026
JO  - Cancer research
DO  - 10.1158/0008-5472.can-25-5172
UR  - https://doi.org/10.1158/0008-5472.can-25-5172
ER  -

APA

A, M., IM, G., S, S. J., P, R., C, R., C, T., BMG, B., C, S., I, F., A, O. C., S, J., S, H., SM, R., R, E., MJ, N., JM, M., D, L., E, G., C, S. A., C, A., A, V., S, V., A, R., D, S., & C, M. (2026). Targeted KRASG12V Degradation In Vivo Elicits Lung Adenocarcinoma Regression with Subsequent Relapse from Dysregulated Proteolysis.. Cancer research. https://doi.org/10.1158/0008-5472.can-25-5172

Source records

pubmed · retrieved 2026-09-26T10:43:12.055Z